Maximizing Response in Acute Leukemia: Pearls From ASH 2017
Drs Cortes and DeAngelo highlight the most intriguing clinical trials presented in the field of leukemia at ASH 2017. (Source: Medscape Oncology)
Source: Medscape Oncology - January 29, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
The Four Studies That Changed Thoracic Oncology in 2017
Dr Mark Kris on how 2017 clarified the importance of achieving progression-free survival in lung cancer patients. (Source: Medscape Oncology)
Source: Medscape Oncology - January 25, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
More Intense Neoadjuvant ECX Regimen Fails for Esophageal Cancer
Dr Kerr reports on a large, well-designed trial with disappointing results. (Source: Medscape Oncology)
Source: Medscape Oncology - January 25, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Oral HPV Infection Rate Is Alarmingly High in US Men
A large population-based study argues for more rigorous efforts to vaccinate against HPV infection and prevent subsequent head and neck cancers, says Dr Markman. (Source: Medscape Oncology)
Source: Medscape Oncology - January 25, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
'Cultural Change' in DCIS
Some think it ' s time to change how we talk about DCIS and to consider de-escalation of therapy. Drs Kathy Miller and Shelley Hwang discuss these hot topics and the COMET study at SABCS 2017. (Source: Medscape Oncology)
Source: Medscape Oncology - January 17, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Late Recurrence in ER- Positive Breast Cancer: Banking on Biomarkers
Evaluation of biomarkers after 5 years of standard therapy for hormone-positive breast cancer may help determine those at risk for recurrence and those who may need further endocrine therapy. (Source: Medscape Oncology)
Source: Medscape Oncology - January 17, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
New GI Cancer Studies: Curious Failures, Hidden Gems
Dr John Marshall on recent publications, both positive and negative, that may change your practice. (Source: Medscape Oncology)
Source: Medscape Oncology - January 3, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Will Immunotherapy Be a PANACEA for Breast Cancer?
Drs Kathy Miller and Sherene Loi discuss advances in immunotherapy for breast cancer, particularly in HER2-positive disease and TNBC. (Source: Medscape Oncology)
Source: Medscape Oncology - January 2, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
For Low-Level HER2 Breast Cancer, Trastuzumab Is a No-Go
Although the study didn ' t turn out as hoped, NSABP B-47 will help inform the decision of whether patients with low-level HER2 breast cancer should receive trastuzumab. (Source: Medscape Oncology)
Source: Medscape Oncology - December 29, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Seeking Consensus Amid Abundant New Lung Cancer Data
Dr Mark Kris on the big take-away lessons from the recent New York Lung Cancers Symposium. (Source: Medscape Oncology)
Source: Medscape Oncology - December 28, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Does Breast Cancer Risk REACT to Celecoxib?
Does this COX-2 inhibitor alter breast cancer risk? Dr Kathy Miller discusses the results of the REACT trial with its primary investigator, Dr Charles Coombes. (Source: Medscape Oncology)
Source: Medscape Oncology - December 27, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Clear Path to Reducing Cancer Risk in China
Dr David Kerr describes an epidemiologic study that found three standout risk factors for cancer in Chinese men and women. (Source: Medscape Oncology)
Source: Medscape Oncology - December 21, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Oncologists Need to Encourage Their Patients to Exercise
Even a brief conversation about exercise can reap significant health benefits to patients, argues Dr Markman. (Source: Medscape Oncology)
Source: Medscape Oncology - December 18, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Chemotherapy or Palliative Care: How to Decide?
The sign of a mature oncologist is knowing when not to treat someone, says Dr Kerr. A new tool may bolster that knowledge. (Source: Medscape Oncology)
Source: Medscape Oncology - December 15, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Hormonal Therapy in Advanced Endometrial Cancer
This meta-analysis may finally clarify which patients are most likely to respond to hormonal therapy. (Source: Medscape Oncology)
Source: Medscape Oncology - December 15, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
